CheckRare

NMOSD Research Highlights from AAN 2020

Overview / Abstract:	Although the 2020 Annual Meeting of the American Academy of Neurology did not take place as scheduled, abstracts including new information and data on neuromyelitis optica spectrum disorder (NMOSD) were published. This CME/CNE activity provides highlights of the latest information about NMOSD and along with expert analysis of its potential clinical relevance for members of the care team in order to help them care for patients with this rare disease.
Expiration	Jul 31, 2021
Discipline(s)	Nurse Practitioner , Nursing CNE, Physician CME, Physician Assistant CME
Format	Webinar / Webcast / Video
Credits / Hours	.25
Accreditation	American Academy of CME, Inc.
Is This Activity Certified for "Live" Credit?	YES
Presenters / Authors / Faculty	Michael Levy, MD, PhD Associate Professor, Harvard Medical School Director, Neuromyelitis Optica Clinic and Research Laboratory Research Director, Division of Neuroimmunology & Neuroinfectious Disease Massachusetts General Hospital
Activity Specialities / Related Topics	Pediatrics, Neurology, Family Medicine
Sponsors / Supporters / Grant Providers	Alexion Pharmaceuticals
Keywords / Search Terms	CheckRare neuromyelitis optica spectrum disorder, NMOSD, Alexion Pharmaceuticals, Michael Levy MD PhD, Neuromyelitis Optica, Harvard Medical School, rare disease, rare disorder, rare neurological disorder, Free CE CME Live CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map